Engineering Gut Microbiome to Target Breast Cancer
Status: | Recruiting |
---|---|
Conditions: | Breast Cancer, Cancer |
Therapuetic Areas: | Oncology |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 12/2/2017 |
Start Date: | October 11, 2017 |
End Date: | August 2018 |
Contact: | Jackie Joy |
Email: | joy.jacqueline@mayo.edu |
Phone: | 904-953-8911 |
The purpose of this study is to find out if using probiotics will help the body's immune
system react to breast cancer. New studies showed that diverse species of bacteria inside the
bowel might help improve immune system, particularly the ability of immune system to
recognize cancer. This study will investigate how probiotics will affect the subjects' immune
system on breast cancer.
system react to breast cancer. New studies showed that diverse species of bacteria inside the
bowel might help improve immune system, particularly the ability of immune system to
recognize cancer. This study will investigate how probiotics will affect the subjects' immune
system on breast cancer.
Inclusion Criteria:
- Post-menopausal females ≥ 18 years of age
- Histologically confirmed adenocarcinoma of the breast ≥1.0 cm operable stage I-III
- Must have adequate organ function,
- Not receive systemic neoadjuvant therapy
- Be willing to provide tissue, blood, and stool samples for research study.
- Must not have taken any probiotics in the past 60 days prior to enrollment.
Exclusion Criteria:
- Patients with autoimmune disease, immune deficiency such as HIV, irritable bowel,
known diverticulosis, and other serious GI conditions at treating physician's
discretion will be excluded.
We found this trial at
1
site
4500 San Pablo Rd S
Jacksonville, Florida 32224
Jacksonville, Florida 32224
(904) 953-2000
Principal Investigator: Saranya Chumsri
Mayo Clinic Florida Thousands of people come to Mayo Clinic in Jacksonville, Fla., annually for...
Click here to add this to my saved trials